摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

FDAA | 139601-90-4

中文名称
——
中文别名
——
英文名称
FDAA
英文别名
N-(5-fluoro-2,4-dinitrophenyl)-l-alanine amide;(2S)-2-amino-N-(5-fluoro-2,4-dinitrophenyl)propanamide
FDAA化学式
CAS
139601-90-4
化学式
C9H9FN4O5
mdl
——
分子量
272.193
InChiKey
JEBYGZRPAMNXRD-BYPYZUCNSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    491.9±45.0 °C(Predicted)
  • 密度:
    1.592±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    19
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.22
  • 拓扑面积:
    147
  • 氢给体数:
    2
  • 氢受体数:
    7

反应信息

  • 作为反应物:
    描述:
    FDAAD-苯丙氨酸三乙胺 作用下, 以 丙酮乙腈 为溶剂, 生成
    参考文献:
    名称:
    Perthamides C and D, two new potent anti-inflammatory cyclopeptides from a Solomon Lithistid sponge Theonella swinhoei
    摘要:
    Two new metabolites, perthamides C and D, have been isolated from the marine sponge Theonella swinhoei. Their structures were determined by interpretation of NMR and ESIMS data. All compounds exhibited in vivo potent anti-inflammatory activity. Biological activity and structural elucidation are reported. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tet.2009.10.026
点击查看最新优质反应信息

文献信息

  • [EN] SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS TRK KINASE INHIBITORS<br/>[FR] COMPOSÉS DE PYRAZOLO[1,5-A]PYRIMIDINE SUBSTITUÉS COMME INHIBITEURS DE LA TRK KINASE
    申请人:ARRAY BIOPHARMA INC
    公开号:WO2010048314A1
    公开(公告)日:2010-04-29
    Compounds of Formula (I) in which R1, R2, R3, R4, X, Y and n have the meanings given in the specification, are inhibitors of Trk kinases and are useful in the treatment of diseases which can be treated with a Trk kinase inhibitor.
    式(I)中R1、R2、R3、R4、X、Y和n的化合物具有规范中给定的含义,是Trk激酶的抑制剂,并且在治疗可以用Trk激酶抑制剂治疗的疾病中是有用的。
  • Process for the synthesis of chirally pure beta-amino-alcohols
    申请人:Wyeth
    公开号:US20030144531A1
    公开(公告)日:2003-07-31
    A process is provided for preparing chirally pure S-enantiomers of &agr;-amino acids comprising the steps of: a) preparing an organometallic reagent from an alkyl halide of the formula (R) 2 CH(CH 2 ) n CH 2 X; b) adding the organometallic reagent to carbon dioxide to afford a carboxylic acid; c) activating the carboxylic acid with an acid chloride, phosphorus trichloride, acid anhydride, or thionyl chloride in the presence of a tertiary amine base; d) reacting the product of step c) with an alkali metal salt of S-4-benzyl-2-oxazolidinone; e) treating the product of step d) with a strong non-nucleophilic base to form an enolate anion; f) trapping the enolate anion with 2,4,6-triisopropylbenzenesulfonyl azide to afford an oxazolidinone azide; g) hydrolyzing the oxazolidinone azide with an aqueous base to afford an &agr;-azido acid; h) reducing the &agr;-azido acid to the &agr;-amino acid; and i) recrystallizing the &agr;-amino acid to the chirally pure &agr;-amino acid. A process is also provided for preparing chirally pure S-enantiomers of &bgr;-amino alcohols further comprising the steps of reducing the crude &agr;-amino acid to the &bgr;-amino alcohol and recrystallizing the &bgr;-amino alcohol to the chirally pure &bgr;-amino alcohol. A process is further provided for preparing chirally pure S enantiomers of N-sulfonyl &bgr;-amino alcohols further comprising the steps of sulfonylating the &bgr;-amino alcohol with 5-chloro-thiophene-2-sulfonyl halide; and recrystallizing to afford the chirally pure N-sulfonyl &bgr;-amino alcohols.
    提供了一种制备手性纯S-对映体α-氨基酸的过程,包括以下步骤:a) 从具有化学式(R)2CH(CH2)nCH2X的烷基卤化物制备有机金属试剂;b) 将有机金属试剂加入二氧化碳以得到羧酸;c) 在三级胺碱存在下,用酸氯化物、三氯化磷、酸酐或氯化硫酰氯激活羧酸;d) 将步骤c)的产物与S-4-苄基-2-噁唑烷酮的碱金属盐反应;e) 用强非亲核碱处理步骤d)的产物以形成烯醇负离子;f) 用2,4,6-三异丙基苯磺酰氮化物捕获烯醇负离子以得到噁唑烷酮氮化物;g) 用水性碱水解噁唑烷酮氮化物以得到α-叠氮酸;h) 还原α-叠氮酸以得到α-氨基酸;i) 对α-氨基酸进行再结晶以得到手性纯α-氨基酸。还提供了一种制备手性纯S-对映体β-氨基醇的过程,进一步包括将粗α-氨基酸还原为β-氨基醇,并对β-氨基醇进行再结晶以得到手性纯β-氨基醇。还提供了一种制备手性纯S-对映体N-磺酰基β-氨基醇的过程,进一步包括用5-氯硫代苯磺酰卤化物对β-氨基醇进行磺酰化;并进行再结晶以得到手性纯N-磺酰基β-氨基醇。
  • Jaspamides M–P: new tryptophan modified jaspamide derivatives from the sponge Jaspis splendans
    作者:Fulvio Gala、Maria Valeria D'Auria、Simona De Marino、Valentina Sepe、Franco Zollo、Charles D. Smith、Staci N. Keller、Angela Zampella
    DOI:10.1016/j.tet.2008.10.076
    日期:2009.1
    Four new jaspamide derivatives with antimicrofilament activity were isolated from the marine sponge Jaspis splendans. Their structures were elucidated by NMR and MS analysis. A structure–activity relationship analysis on all natural jaspamides is also reported here.
    从海洋海绵Jaspis splendans中分离到四种具有抗微丝活性的新的jaspamide衍生物。通过NMR和MS分析阐明了它们的结构。此处还报告了对所有天然jaspamides的构效关系分析。
  • Fast Detection of Two Smenamide Family Members Using Molecular Networking
    作者:Alessia Caso、Germana Esposito、Gerardo Della Sala、Joseph R. Pawlik、Roberta Teta、Alfonso Mangoni、Valeria Costantino
    DOI:10.3390/md17110618
    日期:——
    Caribbean sponges of the genus Smenospongia are a prolific source of chlorinated secondary metabolites. The use of molecular networking as a powerful dereplication tool revealed in the metabolome of S. aurea two new members of the smenamide family, namely smenamide F (1) and G (2). The structure of smenamide F (1) and G (2) was determined by spectroscopic analysis (NMR, MS, ECD). The relative and the
    加勒比海海绵体(Smenospongia)属是氯化次生代谢产物的丰富来源。分子网络作为强大的去复制工具的使用在金黄色葡萄球菌的代谢组中揭示了smenamide家族的两个新成员,即smenamide F(1)和G(2)。通过光谱分析(NMR,MS,ECD)确定酰胺F(1)和G(2)的结构。根据1,3-二取代烷基链系统(即C-12 / C-18链段)的构象刚度,确定C-13,C-15和C-16处的相对和绝对构型化合物(1)的显示:Smenamide F(1)和G(2)对癌细胞系MCF-7和MDA-MB-231具有选择性的适度抗增殖活性,而对MG-63无活性。
  • Recombinant <scp>l</scp> ‐Amino Acid Oxidase with Broad Substrate Spectrum for Co‐substrate Recycling in ( <i>S</i> )‐Selective Transaminase‐Catalyzed Kinetic Resolutions
    作者:Tobias Heinks、Jannik Paulus、Simon Koopmeiners、Tobias Beuel、Norbert Sewald、Matthias Höhne、Uwe T. Bornscheuer、Gabriele Fischer von Mollard
    DOI:10.1002/cbic.202200329
    日期:2022.8.17
    system consisting of a heterologous expressed and highly active l-amino acid oxidase combined with a catalase was applied for kinetic resolutions to produce enantiopure (R)-amines in ω-(S)-transaminase catalyzed reactions. Consequently, catalytic instead of stoichiometric amounts of co-substrate can be applied in preparative scale reactions.
    一种由异源表达的高活性l-氨基酸氧化酶与过氧化氢酶结合组成的高效共底物循环系统被应用于动力学分解,以在ω-(S)-转氨酶催化反应中产生对映体纯( R ) -胺。因此,催化而不是化学计量量的共底物可以应用于制备规模反应。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物